Delivery Order SPE2DB25D3201-SPE2DB25FNNVY

Award Date 11/13/24
Potential Completion Date 12/5/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML. The award has a ceiling value of $2,353.68 and is a firm fixed-price contract with a completion date of June 27, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML, a specialty medication. The firm-fixed-price delivery order, valued at $2,150.36, has a period of performance through September 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,942.10, is for the supply of the pharmaceutical product PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML. The contract has a firm fixed price pricing type and an ultimate completion date of January 29, 2025. This contract is not associated with a set-aside program. AmerisourceBergen holds a larger...
This is a $1,176.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML, a medical product, with a performance period through June 20, 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price type and a ceiling value of $5,884.20. The contract is for the pharmaceutical product PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML, with a performance period through June 25, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML, a prescription medication. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $1,765.26 and a period of performance through May 19, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML, a prescription medication. The $3,225.54 firm-fixed-price Delivery Order has an ultimate completion date of August 6, 2024. This award is not associated with a set-aside program. Amerisourcebergen has significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,150.36 order is for the pharmaceutical product PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML, with a completion date of March 15, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,176.84 and covers the delivery of the pharmaceutical product PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 30, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is a delivery order with a ceiling value of $1,075.18 for the supply of the pharmaceutical product PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML. The contract was awarded on September 23, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of October 15, 2024. This award is not associated with a set-aside program and is a firm fixed-price contract. Amerisourcebergen, a...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNNVY
    Delivery Order

This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,075.18, is for the delivery of the specialty medication PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML. The contract has an ultimate completion date of December 5, 2024 and is a firm fixed-price delivery order. There is no set-aside designation noted for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/20/25, 2:28 PM